D

CapsoVision, Inc. CV

$6.92 $0.274.06% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

CapsoVision, Inc. (NASDAQ: CV) is a medical technology company focused on capsule endoscopy systems used for gastrointestinal diagnostics. The company develops ingestible imaging capsules and related software platforms that allow physicians to visualize the gastrointestinal tract, particularly the small bowel, in a minimally invasive manner. CapsoVision operates within the broader healthcare technology and medical device industries, with its primary commercial focus centered on diagnostic imaging solutions for gastroenterology practices, hospitals, and ambulatory care providers.

The company’s principal product platform is the CapsoCam capsule endoscopy system, which combines onboard image storage, panoramic imaging capabilities, and physician review software. Revenue is primarily generated through the sale of capsule endoscopy devices, associated software, and related clinical solutions. CapsoVision’s strategic positioning has centered on differentiated capsule imaging technology designed to improve visualization and patient convenience relative to traditional wired endoscopy procedures. Public filings and company disclosures indicate that the business evolved from a specialized gastrointestinal imaging developer into a commercially focused medical device company targeting broader adoption across digestive disease diagnostics.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range23% of range
Low
$4.34
Current
$6.92
High
$15.37
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
408 624 1488
Address
18805 Cox Avenue
Suite 250
Saratoga, CA 95070
Country
Year Founded

Headlines

8/14/2026 - Seeking Alpha: Transcripts